BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 23552863)

  • 21. Angiotensin-converting enzyme 2 ameliorates renal fibrosis by blocking the activation of mTOR/ERK signaling in apolipoprotein E-deficient mice.
    Chen LJ; Xu YL; Song B; Yu HM; Oudit GY; Xu R; Zhang ZZ; Jin HY; Chang Q; Zhu DL; Zhong JC
    Peptides; 2016 May; 79():49-57. PubMed ID: 27018342
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Loss of angiotensin-converting enzyme-2 (Ace2) accelerates diabetic kidney injury.
    Wong DW; Oudit GY; Reich H; Kassiri Z; Zhou J; Liu QC; Backx PH; Penninger JM; Herzenberg AM; Scholey JW
    Am J Pathol; 2007 Aug; 171(2):438-51. PubMed ID: 17600118
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Angiotensin II type 2 receptor and angiotensin-converting enzyme 2 mediate ischemic renal injury in diabetic and non-diabetic rats.
    Sharma N; Malek V; Mulay SR; Gaikwad AB
    Life Sci; 2019 Oct; 235():116796. PubMed ID: 31470003
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Angiotensin 1-7 mediates renoprotection against diabetic nephropathy by reducing oxidative stress, inflammation, and lipotoxicity.
    Mori J; Patel VB; Ramprasath T; Alrob OA; DesAulniers J; Scholey JW; Lopaschuk GD; Oudit GY
    Am J Physiol Renal Physiol; 2014 Apr; 306(8):F812-21. PubMed ID: 24553436
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential renal effects of candesartan at high and ultra-high doses in diabetic mice-potential role of the ACE2/AT2R/Mas axis.
    Callera GE; Antunes TT; Correa JW; Moorman D; Gutsol A; He Y; Cat AN; Briones AM; Montezano AC; Burns KD; Touyz RM
    Biosci Rep; 2016 Oct; 36(5):. PubMed ID: 27612496
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angiotensin-converting enzyme 2 influences pancreatic and renal function in diabetic mice.
    Roca-Ho H; Palau V; Gimeno J; Pascual J; Soler MJ; Riera M
    Lab Invest; 2020 Sep; 100(9):1169-1183. PubMed ID: 32472097
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overexpression of Nrf2 in Renal Proximal Tubular Cells Stimulates Sodium-Glucose Cotransporter 2 Expression and Exacerbates Dysglycemia and Kidney Injury in Diabetic Mice.
    Zhao S; Lo CS; Miyata KN; Ghosh A; Zhao XP; Chenier I; Cailhier JF; Ethier J; Lattouf JB; Filep JG; Ingelfinger JR; Zhang SL; Chan JSD
    Diabetes; 2021 Jun; 70(6):1388-1403. PubMed ID: 33820760
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Angiotensin II up-regulates sodium-glucose co-transporter 2 expression and SGLT2 inhibitor attenuates Ang II-induced hypertensive renal injury in mice.
    Miyata KN; Lo CS; Zhao S; Liao MC; Pang Y; Chang SY; Peng J; Kretzler M; Filep JG; Ingelfinger JR; Zhang SL; Chan JSD
    Clin Sci (Lond); 2021 Apr; 135(7):943-961. PubMed ID: 33822013
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Angiotensin-converting enzyme (ACE) 2 overexpression ameliorates glomerular injury in a rat model of diabetic nephropathy: a comparison with ACE inhibition.
    Liu CX; Hu Q; Wang Y; Zhang W; Ma ZY; Feng JB; Wang R; Wang XP; Dong B; Gao F; Zhang MX; Zhang Y
    Mol Med; 2011; 17(1-2):59-69. PubMed ID: 20844835
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heterogeneous Nuclear Ribonucleoprotein F Mediates Insulin Inhibition of Bcl2-Modifying Factor Expression and Tubulopathy in Diabetic Kidney.
    Ghosh A; Zhao S; Lo CS; Maachi H; Chenier I; Lateef MA; Abdo S; Filep JG; Ingelfinger JR; Zhang SL; Chan JSD
    Sci Rep; 2019 Apr; 9(1):6687. PubMed ID: 31040360
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Angiotensin-converting enzyme 2 and the kidney.
    Soler MJ; Wysocki J; Batlle D
    Exp Physiol; 2008 May; 93(5):549-56. PubMed ID: 18223023
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Angiotensin-converting enzyme 2 mediates hyperfiltration associated with diabetes.
    Tikellis C; Brown R; Head GA; Cooper ME; Thomas MC
    Am J Physiol Renal Physiol; 2014 Apr; 306(7):F773-80. PubMed ID: 24477684
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Angiotensin-converting enzyme 2 amplification limited to the circulation does not protect mice from development of diabetic nephropathy.
    Wysocki J; Ye M; Khattab AM; Fogo A; Martin A; David NV; Kanwar Y; Osborn M; Batlle D
    Kidney Int; 2017 Jun; 91(6):1336-1346. PubMed ID: 27927599
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Angiotensin-(1-7) Attenuates Kidney Injury Due to Obstructive Nephropathy in Rats.
    Kim CS; Kim IJ; Bae EH; Ma SK; Lee J; Kim SW
    PLoS One; 2015; 10(11):e0142664. PubMed ID: 26556707
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Angiotensin-converting enzyme 2: enhancing the degradation of angiotensin II as a potential therapy for diabetic nephropathy.
    Batlle D; Wysocki J; Soler MJ; Ranganath K
    Kidney Int; 2012 Mar; 81(6):520-8. PubMed ID: 22113528
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel roles of the renal angiotensin-converting enzyme.
    Giani JF; Veiras LC; Shen JZY; Bernstein EA; Cao D; Okwan-Duodu D; Khan Z; Gonzalez-Villalobos RA; Bernstein KE
    Mol Cell Endocrinol; 2021 Jun; 529():111257. PubMed ID: 33781839
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Brain-selective overexpression of human Angiotensin-converting enzyme type 2 attenuates neurogenic hypertension.
    Feng Y; Xia H; Cai Y; Halabi CM; Becker LK; Santos RA; Speth RC; Sigmund CD; Lazartigues E
    Circ Res; 2010 Feb; 106(2):373-82. PubMed ID: 19926873
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of prolyl carboxypeptidase as an alternative enzyme for processing of renal angiotensin II using mass spectrometry.
    Grobe N; Weir NM; Leiva O; Ong FS; Bernstein KE; Schmaier AH; Morris M; Elased KM
    Am J Physiol Cell Physiol; 2013 May; 304(10):C945-53. PubMed ID: 23392115
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting the degradation of angiotensin II with recombinant angiotensin-converting enzyme 2: prevention of angiotensin II-dependent hypertension.
    Wysocki J; Ye M; Rodriguez E; González-Pacheco FR; Barrios C; Evora K; Schuster M; Loibner H; Brosnihan KB; Ferrario CM; Penninger JM; Batlle D
    Hypertension; 2010 Jan; 55(1):90-8. PubMed ID: 19948988
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Deletion of angiotensin-converting enzyme 2 exacerbates renal inflammation and injury in apolipoprotein E-deficient mice through modulation of the nephrin and TNF-alpha-TNFRSF1A signaling.
    Jin HY; Chen LJ; Zhang ZZ; Xu YL; Song B; Xu R; Oudit GY; Gao PJ; Zhu DL; Zhong JC
    J Transl Med; 2015 Aug; 13():255. PubMed ID: 26245758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.